Prostate Cancer - Results from #1160

Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes. April 8, 2024

Mortality Risks Associated with Depression in Men with Prostate Cancer. April 8, 2024

Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations. April 8, 2024

Novartis Confirms Plans to File for Pluvicto® Pre-Taxane Label Expansion in H2 2024 Based on Latest Data from Phase III PSMAfore Study April 5, 2024

Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer. April 5, 2024

Variation in management of lymph node positive prostate cancer after radical prostatectomy within a statewide quality improvement consortium. April 5, 2024

Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer. April 5, 2024

Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis. April 5, 2024

Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform. April 5, 2024

Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Tria April 5, 2024

A Single-Institution Prospective Study To Evaluate the Safety and Efficacy of Real- Time Image-Gated Spot-Scanning Proton Therapy (RGPT) for Prostate Cancer. April 4, 2024

Pretreatment Patient-reported Overall Health: A Prognostic Factor for Early Overall Mortality After Primary Curative Treatment of Prostate Cancer. April 4, 2024

Combination of prostate volume and apparent diffusion coefficient can stratify patients with a PI-RADS score of 3 to reduce unnecessary prostate biopsies. April 4, 2024

Adequacy of prostate cancer prevention and screening recommendations provided by an artificial intelligence-powered large language model. April 4, 2024

Photon vs proton hypofractionation in prostate Cancer: A systematic review and meta-analysis. April 4, 2024

A body shape index (ABSI) but not body mass index (BMI) is associated with prostate cancer-specific mortality: Evidence from the US NHANES database. April 4, 2024

Prostate-Specific Antigen Screening in Smokers: A Comprehensive Analysis Using a National Behavioral Survey. April 4, 2024

Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castrate-Resistant Prostate Cancer Setting: A Systematic Review and Meta-Analysis April 3, 2024

Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting. April 3, 2024

CDK12 Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic Lethality. April 3, 2024

Page 59 of 1438